Is Thymosin Alpha-1 Legal in Wisconsin? How to Access It Legally

HealthRX.com

FDA gives thymosin alpha-1 no approval or recognized pathway

Print or save as PDF

Key numbers

  • 1.6 mgDose on the Italian Zadaxin label, which has no US-approved equivalentSource: fda.gov, as cited Nov 7, 2026
  • 45.8%HBeAg loss at 72 weeks with interferon plus thymosin alpha-1 in one trial of 98 adultsSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 1,349 adultsAdults with chronic hepatitis B pooled across 10 trials in a 2026 Cochrane reviewSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • FDA approval / none; no US application for thymosin alpha-1 or thymalfasin [1]
  • State-licensed pharmacy list / in none of the three categories, updated May 14, 2026 [2]
  • Outsourcing facility list / category 3, 'nominated without adequate support', updated March 21, 2025 [3]
  • FDA safety view / immunogenicity for certain routes, peptide purity and characterization, safety data inadequate [4]
  • Advisory committee vote / 4 yes, 17 no, December 4, 2024 [5]
  • Approved outside the US / Italy as an influenza-vaccine adjuvant, India for chronic hepatitis B, Hong Kong [1]
  • US-approved dose / none [1]

Is thymosin alpha-1 FDA-approved?

No. A Drugs@FDA search found no US application for thymosin alpha-1 or thymalfasin [1]. It holds four US orphan drug designations, but orphan designation is a separate process from approval [1]. Zadaxin, the finished 1.6 mg injection sold outside the US, is not interchangeable with bulk thymosin alpha-1 powder [1].

What do FDA's compounding lists say?

State-licensed pharmacies compound against patient-specific prescriptions; outsourcing facilities may also distribute compounded drugs for office stock without a patient-specific prescription [6]. FDA keeps a separate bulk-substance list for each.

On the state-licensed pharmacy list, updated May 14, 2026, thymosin alpha-1 is in none of the three categories, so FDA's category 1 policy of generally taking no action against qualifying compounders does not apply to it [2][3]. On the outsourcing facility list, updated March 21, 2025, it is in category 3, 'nominated without adequate support' [3].

FDA's stated concerns remain posted: 'significant risk for immunogenicity for certain routes of administration', peptide-impurity and characterization problems, and safety information 'inadequate for the agency to sufficiently understand the extent of any safety issues' [4]. Thymosin alpha-1 now sits in the 'nominated but withdrawn' table on that page because the nominators withdrew it [4].

On December 4, 2024, FDA's Pharmacy Compounding Advisory Committee voted 4 yes and 17 no on both the free base and the acetate; members who voted no cited no compelling evidence of clinical effectiveness and safety [5]. Thymosin alpha-1 is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy [7].

Where does that leave access?

There is no FDA-approved thymosin alpha-1 product in the US [1]. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they reach patients [6].

Questions worth asking

Choose the questions you want to keep

What do the trials and the label show?

The Italian Zadaxin label gives 1.6 mg subcutaneously or intramuscularly twice weekly for 4 weeks from the first vaccination, repeated from week 8 to week 12, and contraindicates it in pregnancy and breastfeeding [1]. No US-approved dose exists [1].

A 2026 Cochrane review pooled 10 randomized trials in 1,349 adults with chronic hepatitis B and rated the effect on hepatitis B-related illness very uncertain; the reviewers said they were 'not sure' the drug helps [8]. In one double-blind trial of 98 adults, HBeAg loss at 72 weeks was 45.8% with interferon plus thymosin alpha-1 versus 28.0% with interferon plus placebo, a difference of 17.8% (95% CI -1.2 to 35.3, P=0.067) that was not statistically significant [9].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. How many yes and no votes did FDA's advisory committee cast on the thymosin alpha-1 question on December 4, 2024?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Is thymosin alpha-1 legal in Wisconsin?
Federally it has no FDA approval, is in none of the three categories on FDA's state-licensed pharmacy bulk list, and is category 3 for outsourcing facilities [1][2][3]. Wisconsin-specific rules are not established by these federal lists.
Do compounded drugs need a patient-specific prescription?
State-licensed pharmacies compound against patient-specific prescriptions; outsourcing facilities may also distribute compounded drugs for office stock without one [6].
Is thymosin alpha-1 banned in sport?
WADA's 2026 Prohibited List does not name thymosin alpha-1; it names thymosin-beta-4 and derivatives such as TB-500 in S2.3, a different peptide [10].
Why did FDA's advisory committee vote against it?
Members who voted no cited no compelling evidence of clinical effectiveness and safety [5].
Show all 10 referencesHide references
  1. U.S. Food and Drug Administration. Thymosin alpha-1 review, December 2024.
  2. U.S. Food and Drug Administration. Bulk drug substances list for state-licensed pharmacies and physicians.
  3. U.S. Food and Drug Administration. Bulk drug substances list for outsourcing facilities.
  4. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  5. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee, December 4, 2024.
  6. Human Drug Compounding Laws | FDA.
  7. U.S. Department of Health and Human Services. Peptide enforcement discretion policy, Appendix B. HHS peptide enforcement discretion policy
  8. Naing C, Ni H, Aung HH, Aye SN, Nikolova D, Poovorawan Y, et al. Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database Syst Rev. 2026.
  9. Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, et al. A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B. Antivir Ther. 2006.
  10. World Anti-Doping Agency. 2026 Prohibited List.
Evidence overview for Is Thymosin Alpha-1 Legal in Wisconsin? How to Access It Legally